Format

Send to

Choose Destination
J Lab Physicians. 2018 Oct-Dec;10(4):406-409. doi: 10.4103/JLP.JLP_85_18.

Clinico-microbiological profile of healthcare associated pneumonia in critically ill patients at level-I trauma centre of India.

Author information

1
Division of Trauma Surgery and Critical Care, JPNATC, AIIMS, New Delhi, India.
2
Department of Laboratory Medicine, JPNATC, AIIMS, New Delhi, India.
3
Department of Orthopaedics, AIIMS, New Delhi, India.

Abstract

INTRODUCTION:

Device-associated infections constitute the majority of health-care infections in Intensive Care Units (ICUs). Trauma patients are more prone to acquire such infections; ventilator-associated pneumonia (VAP) being the most common Health care associated infections (HAI) in ICU has serious implications such as increased morbidity, prolonged hospital stay, and mortality. This study aims to compare the clinicomicrobiological profile of VAP and non-VAP trauma patients at Level I trauma center.

MATERIALS AND METHODS:

A 4-year retrospective study of prospectively maintained database was conducted at Level 1 trauma center from January 2013 to December 2016. The patients were classified into two groups named VAP and non-VAP patients. VAP patients were defined according to the criteria of the Centers for Disease Control and Prevention. The data were compiled and analyzed. Statistical data were analyzed using SPSS version 21 software.

RESULTS:

During the study period, 134 (13%) cases of VAP and 909 (87%) non-VAP cases were observed in our study. The total number of ventilator days for VAP patients was 5128 days, which ranged from 2 to 82 days (median 42 days). The length of hospital stay in non-VAP category ranged from 1 to 390 days (median 195.5 days). Inhospital mortality was observed in 62 (46%) patients with VAP. Three hundred and eighteen (35%) non-VAP patients had also had a fatal outcome. Gram-negative organisms, most commonly Acinetobacter spp. (13, 21%), were reported in the fatal VAP patients.

CONCLUSION AND DISCUSSION:

Higher rate of mortality was observed in patients with VAP in comparison to non-VAP patients, both being on mechanical ventilation. Early recognition of VAP, implementation of proper VAP preventive bundle strategies, and stringent infection control practices are essential mandates to prevent VAP.

KEYWORDS:

Antimicrobial; infection; mortality; resistance

Supplemental Content

Full text links

Icon for Medknow Publications and Media Pvt Ltd Icon for PubMed Central
Loading ...
Support Center